Crucell and DSM Announce PER.C6 Licensing Agreement with Symphogen for Polyclonal Antibody Protein Production
15 juil. 2005 02h08 HE
|
Crucell N.V.
LEIDEN, Netherlands, July 15, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have...
Crucell Announces Clinical Development of Human Monoclonal Antibody Combination Against Rabies
14 juil. 2005 02h14 HE
|
Crucell N.V.
LEIDEN, Netherlands, July 14, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced plans for the clinical development of its combination of two...
Crucell NV Options to be Listed on Euronext.liffe Amsterdam
13 juil. 2005 11h57 HE
|
Crucell N.V.
LEIDEN, Netherlands, July 13, 2005 (PRIMEZONE) -- Euronext.liffe today announced that options for Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) are to be listed on...
Crucell to Release Second Quarter Results on Monday, July 18
05 juil. 2005 08h17 HE
|
Crucell N.V.
LEIDEN, Netherlands, July 5, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Nasdaq:CRXL) (Euronext:CRXL) today announced that it will release its financial results for the second...
Fidelity Fund Acquires 5.13 Percent Interest in Crucell
28 juin 2005 02h07 HE
|
Crucell N.V.
LEIDEN, Netherlands, June 28, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Fidelity's FID Growth Company Fund has acquired a 5.13%...
Human Monoclonal Antibody Against West Nile Virus Shows Promise in Animal Studies
10 juin 2005 08h13 HE
|
Crucell N.V.
LEIDEN, Netherlands, June 10, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announces the discovery of a monoclonal antibody for protection against...
Crucell announces STAR(TM) Arrangement with Medarex
01 juin 2005 02h05 HE
|
Crucell N.V.
LEIDEN, Netherlands, June 1, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has started an evaluation program with Medarex, Inc.,...
Crucell NV Options Listed on Chicago Board Options Exchange
31 mai 2005 02h36 HE
|
Crucell N.V.
LEIDEN, Netherlands, May 31, 2005 (PRIMEZONE) -- Options for Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) have been listed on the Chicago Board Options Exchange (CBOE), the...
Crucell and DSM Announce PER.C6(R) License Agreement with Ferring Pharmaceuticals
25 mai 2005 02h04 HE
|
Crucell N.V.
LEIDEN, Netherlands, May 25, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have...
Crucell to Present at Needham & Company Fourth Annual Biotechnology Conference, May 26
20 mai 2005 12h22 HE
|
Crucell N.V.
LEIDEN, Netherlands, May 20, 2005 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced that its Chief Financial Officer, Leonard Kruimer, will present at the Annual Needham &...